Hofseth BioCare ASA
Symbool: HBC.OL
OSL
2.09
NOKMarktprijs vandaag
-7.7400
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
825.72M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Hofseth BioCare ASA (HBC-OL) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 23.9 | 29.9 | 47.2 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -1 | 0 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 14.8 | 14.1 | 32.3 | ||||||||||||||
balance-sheet.row.inventory | 0 | 82.5 | 116.5 | 90.8 | ||||||||||||||
balance-sheet.row.other-current-assets | 0 | 9.7 | 12.7 | 0 | ||||||||||||||
balance-sheet.row.total-current-assets | 0 | 131 | 175.7 | 170.3 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 165.7 | 168.8 | 185.8 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 55.3 | 60.6 | 53.1 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 55.3 | 60.6 | 53.1 | ||||||||||||||
balance-sheet.row.long-term-investments | 0 | 38.1 | 6.9 | 6.8 | ||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | -6.9 | -6.8 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 5.9 | 6.7 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 259.1 | 235.3 | 245.7 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 0 | 390.1 | 411 | 416 | ||||||||||||||
balance-sheet.row.account-payables | 0 | 55.2 | 145.8 | 124.2 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 39.7 | 13.4 | 14.5 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 97.1 | 90.8 | 124.7 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0 | 157 | 13.1 | 12.2 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 97.1 | 90.8 | 124.7 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 96.8 | 102.8 | 113 | ||||||||||||||
balance-sheet.row.total-liab | 0 | 349 | 263 | 275.6 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 0 | 4 | 4 | 3.6 | ||||||||||||||
balance-sheet.row.retained-earnings | 0 | 37.9 | 145.7 | 0 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | -1 | 137.5 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 41.8 | 148.7 | 141.1 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 390.1 | 411 | 416 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | -0.7 | -0.7 | -0.7 | ||||||||||||||
balance-sheet.row.total-equity | 0 | 41.1 | 148 | 140.4 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||
Total Investments | 0 | 38.1 | 5.9 | 6.8 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 136.8 | 104.2 | 139.2 | ||||||||||||||
balance-sheet.row.net-debt | 0 | 112.9 | 74.3 | 92 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -106.7 | -137.4 | -126.5 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 36.4 | 30.4 | 29.4 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 77.4 | 52.1 | 26 | ||||||||||||||
cash-flows.row.account-receivables | 0 | -0.8 | -4 | 4.2 | ||||||||||||||
cash-flows.row.inventory | 0 | 34 | -25.7 | -17.5 | ||||||||||||||
cash-flows.row.account-payables | 0 | 53.4 | 21.6 | 39.2 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -9.2 | 60.2 | 0.1 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -24.5 | 9.8 | 9.4 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -23.7 | -17.8 | -37.8 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | -0.2 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -0.2 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0.2 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -23.7 | -17.8 | -37.9 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -32.6 | -2.4 | -3.4 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | -0.2 | 70.8 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -22.9 | -19.8 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 32.4 | 45.5 | -23.2 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -8.5 | -17.5 | -122.9 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 23.9 | 32.4 | 49.9 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 32.4 | 49.9 | 172.8 | ||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -17.3 | -45.2 | -61.8 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | -23.7 | -17.8 | -37.8 | ||||||||||||||
cash-flows.row.free-cash-flow | 0 | -40.9 | -62.9 | -99.5 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 190.8 | 120.4 | 87.6 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 245.4 | 91.9 | 64.5 | ||||||||||||||
income-statement-row.row.gross-profit | 0 | -54.6 | 28.5 | 23.1 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | -6.1 | 1.6 | 0 | ||||||||||||||
income-statement-row.row.operating-expenses | 0 | 71.6 | 157.1 | 141.7 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 317 | 249.1 | 206.2 | ||||||||||||||
income-statement-row.row.interest-income | 0 | 0.6 | 0.7 | 0.6 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 7.5 | 10 | 9.4 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 16.9 | -8.8 | -7.9 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -6.1 | 1.6 | 0 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 16.9 | -8.8 | -7.9 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 7.5 | 10 | 9.4 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 36.4 | 30.4 | 29.4 | ||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 0 | -126.2 | -128.6 | -118.6 | ||||||||||||||
income-statement-row.row.income-before-tax | 0 | -109.2 | -137.4 | -126.5 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -2.5 | 1.2 | 1.5 | ||||||||||||||
income-statement-row.row.net-income | 0 | -106.7 | -137.4 | -126.5 |
Vaak gestelde vragen
Wat is Hofseth BioCare ASA (HBC.OL) totale activa?
Hofseth BioCare ASA (HBC.OL) totale activa is 390119000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.076.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.552.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.507.
Wat is Hofseth BioCare ASA (HBC.OL) nettowinst (netto-inkomen)?
De nettowinst is -106682000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 136789000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 71606000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.